Arkolith/Insider Trading/IOBT/Form 4

Burkavage Brian

Chief Accounting OfficerIO Biotech, Inc. (IOBT) · full profile →Form 4 · filed Nov 24, 2023
Net Buying
Open-Market Buys
$10K
Open-Market Sells
$0
Net Open-Market Flow
$10K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 22, 2023Buy(P)5K$1.04$5K12K
Nov 21, 2023Buy(P)5K$0.99$5K7K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000905148-23-001527) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML